You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

trivalent vaccine

Showing 1 - 25 of 8,310
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, Vaccines Trial in Santiago (CoronaVac®, Omicron Vaccine, Trivalent Vaccine)

Recruiting
  • COVID-19
  • Vaccines
  • CoronaVac®
  • +2 more
  • Santiago, Metropolitana, Chile
  • +2 more
Jan 12, 2023

COVID-19 Trial in Chengdu (LYB002V14, LYB002V14A, LYB002CA)

Active, not recruiting
  • COVID-19
  • LYB002V14
  • +2 more
  • Chengdu, Sichuan, China
    Affiliated Hospital of North Sichuan MedicalCollege
Jun 29, 2023

COVID-19 Trial (High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), Low dose of Recombinant

Not yet recruiting
  • COVID-19
  • High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell)
  • +3 more
  • (no location specified)
Jun 19, 2023

Poliomyelitis Trial in Geelong, Melbourne (Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio), Inactivated

Not yet recruiting
  • Poliomyelitis
  • Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio)
  • +3 more
  • Geelong, Victoria, Australia
  • +1 more
Oct 30, 2023

Trivalent Salmonella Conjugate Vaccine (TSCV) Trial (TSCV (Full-strength), TSCV (Half-strength), Typbar-TCV)

Not yet recruiting
  • Trivalent Salmonella Conjugate Vaccine (TSCV)
  • TSCV (Full-strength)
  • +3 more
  • (no location specified)
Mar 24, 2023

Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),

Not yet recruiting
  • Poliomyelitis
  • Novel oral poliomyelitis vaccine type 1 (nOPV1)
  • +3 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research
Nov 14, 2023

Rotavirus Infections, Rotavirus Gastroenteritis Trial in Shangqiu (Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine,

Recruiting
  • Rotavirus Infections
  • Rotavirus Gastroenteritis
  • Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine
  • +2 more
  • Shangqiu, Henan, China
  • +1 more
Jan 31, 2023

Influenza Trial in China (Quadrivalent Influenza Vaccine, Trivalent Influenza Vaccine 1 SP Shz TIV1, Trivalent Influenza Vaccine

Completed
  • Influenza
  • Quadrivalent Influenza Vaccine
  • +2 more
  • Kunming, China
  • +6 more
Nov 4, 2022

Rotavirus Vaccine Trial in Johannesburg (RV3-BB, Trivalent P2-VP8, Rotarix)

Completed
  • Rotavirus Vaccine
  • RV3-BB
  • +4 more
  • Johannesburg, Gauteng, South Africa
  • +1 more
Nov 28, 2022

COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for

Not yet recruiting
  • COVID-19
  • SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • Manila, Philippines
  • +2 more
Jun 21, 2023

COVID-19 Trial in Barranquilla (Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron

Not yet recruiting
  • COVID-19
  • Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain
  • COVID-19 Vaccine (Vero Cell), Inactivated
  • Barranquilla, Colombia
    Clinica de la Costa
Jun 23, 2022

Influenza Trial in Bangkok (GPO Tri Fluvac vaccine, Licensed influenza vaccine)

Recruiting
  • Influenza
  • GPO Tri Fluvac vaccine
  • Licensed influenza vaccine
  • Bangkok, Thailand
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
Aug 23, 2022

Seasonal Influenza Trial in China (Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza vaccine(0.5ml), Trivalent

Not yet recruiting
  • Seasonal Influenza
  • Quadrivalent influenza vaccine(0.25ml)
  • +3 more
  • Lu'an, Anhui, China
  • +4 more
Sep 15, 2023

Influenza, Human Trial (Quadrivalent Influenza Vaccine (split virion, inactivated), Trivalent Influenza Vaccine (split virion,

Not yet recruiting
  • Influenza, Human
  • Quadrivalent Influenza Vaccine (split virion, inactivated)
  • +2 more
  • (no location specified)
Mar 9, 2023

Influenza, Hepatitis A, Typhoid Trial in Stanford (Fluzone® quadrivalent, Fluzone High Dose, Fluad)

Active, not recruiting
  • Influenza
  • +3 more
  • Fluzone® quadrivalent
  • +5 more
  • Stanford, California
    Stanford LPCH Vaccine Program
Dec 12, 2022

Influenza Trial in Raleigh, Rocky Mount, Statesville (NanoFlu, Fluzone HD - Day 0, Fluzone HD - Day 21)

Completed
Has Results
  • Influenza
  • NanoFlu
  • +3 more
  • Raleigh, North Carolina
  • +2 more
Nov 29, 2022

Influenza, Human, Transplantation Infection Trial in Falls Church (influenza trivalent inactive vaccine, influenza trivalent

Completed
Has Results
  • Influenza, Human
  • Transplantation Infection
  • influenza trivalent inactive vaccine
  • influenza trivalent inactive vaccine high dose
  • Falls Church, Virginia
    Inova Fairfax Hospital
Jul 20, 2022

Risk Reduction Trial in Baltimore (Trivalent Invasive Salmonella Disease Vaccine (6.25 µg), Trivalent Invasive Salmonella

Completed
  • Risk Reduction
  • Trivalent Invasive Salmonella Disease Vaccine (6.25 µg)
  • +4 more
  • Baltimore, Maryland
    University of Maryland, Baltimore, Center for Vaccine Developmen
Oct 25, 2021

Salmonella Infections Trial (biological, combination product, drug, other)

Not yet recruiting
  • Salmonella Infections
  • Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose
  • +10 more
  • (no location specified)
Jul 27, 2022

COVID-19, Coronavirus Infections Trial in Halifax, Ottawa, Quebec (VBI-2901e)

Not yet recruiting
  • COVID-19
  • Coronavirus Infections
  • VBI-2901e
  • Halifax, Nova Scotia, Canada
  • +3 more
Dec 10, 2022

Seasonal Influenza Trial in Huai'an, Lianyungang, Yancheng (Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza

Recruiting
  • Seasonal Influenza
  • Quadrivalent influenza vaccine(0.25ml)
  • +3 more
  • Huai'an, Jiangsu, China
  • +3 more
Aug 9, 2022

COVID-19, Coronavirus Infections Trial in Canada (VBI-2901a)

Recruiting
  • COVID-19
  • Coronavirus Infections
  • VBI-2901a
  • Halifax, Nova Scotia, Canada
  • +6 more
Nov 16, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (biological, drug, other)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
  • +6 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 24, 2022

Healthy Trial in Rwanda, United States (Ad26.Mos.HIV, Ad26.Mos4.HIV, Clade C gp140)

Completed
  • Healthy
  • Ad26.Mos.HIV
  • +3 more
  • Birmingham, Alabama
  • +9 more
Jul 5, 2022

COVID-19 Trial in Nanjing (recombinant Ad5 vectored COVID-19 vaccine, RBD-based protein subunit vaccine (ZF2001) against

Completed
  • COVID-19
  • recombinant Ad5 vectored COVID-19 vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Diseases Control and Prevention
Mar 28, 2022